NASDAQ:MDRX

Allscripts Healthcare Solutions Stock News

etoro logo Buy MDRX
*Your capital is at risk
$4.75
+0.250 (+5.56%)
At Close: Jun 03, 2026
CHICAGO--(BUSINESS WIRE)-- #healthIT--Which region of the U.S. has the highest rates of hypertension, coronary artery disease and heart failure? The South, according to this analysis on cardiovascular
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the launch of TRANSFORM VAX, an American College of C
SAN DIEGO , Feb. 6, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit is pending for certain investors in Veradigm Inc. (NASDAQ: MDRX) shares. Investors, who purchased sh
NEW YORK , Jan. 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Veradigm Inc. ("Veradigm" or the "Company") (NASDAQ: MDRX). Such investors are adv
LOS ANGELES, CA / ACCESSWIRE / January 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veradigm Inc. ("Veradigm" or "
NEW YORK , Jan. 21, 2024 /PRNewswire/ --  WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Veradigm Inc. f/k/a Allscripts Healthcare Solutions, Inc. (NAS
Veradigm's (MDRX) acquisition of Koha Health will likely enhance its ability to deliver efficient revenue cycle services by incorporating Musculoskeletal Medicine specialty subject matter expertise.
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions, announced today that Dr. Shih-Yin Ho, Veradigm interim Chief Executi
Veradigm's (MDRX) latest solution is likely to offer its clients the right payment option to each individual patient through the right communication channel.
Veradigm's (MDRX) latest progress with FDB Vela is likely to offer prescribers and patients greater choice and cost transparency.
Veradigm's (MDRX) new phase of strategic investment is likely to drive innovation and close the evidence gap in behavioral health.
Veradigm's (MDRX) latest partnership is likely to promote value-based care initiatives for healthcare providers and the patients they serve.
Veradigm Inc. is a small-cap firm in the healthcare industry and its stock is trading near its 52-week low. The company was birthed out of Allscripts Healthcare Solutions, and the new entity provides
Veradigm (MDRX) continues to hold on to investors' interests owing to its strategic alliances.
Here we pick three business service stocks, namely PagSeguro Digital (PAGS), Veradigm (MDRX) and TuSimple (TSP), which are likely to pull off earnings surprises this time around.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE